Metformin: A Potential Therapeutic Tool for Rheumatologists

Metformin: A Potential Therapeutic Tool for Rheumatologists

Metformin is an oral antihyperglycemic drug widely used to treat type 2 diabetes, acting via indirect activation of 5′ Adenosine Monophosphate-activated Protein Kinase (AMPK). Actually, evidence has accumulated of an intriguing anti-inflammatory activity, mainly mediated by AMPK through a variety of...

Full description

Bibliographic Details
Main Authors: Teresa Salvatore, Pia Clara Pafundi, Raffaele Galiero, Klodian Gjeloshi, Francesco Masini, Carlo Acierno, Anna Di Martino, Gaetana Albanese, Maria Alfano, Luca Rinaldi, Ferdinando Carlo Sasso
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Pharmaceuticals
Subjects:
metformin
type 2 diabetes
rheumatology
inflammation
autoimmune diseases
Online Access:https://www.mdpi.com/1424-8247/13/9/234

Internet

https://www.mdpi.com/1424-8247/13/9/234

Similar Items